1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | On 01/27/2023, from 10:13am to 3:38pm, Licensing Program Analyst (LPA) Rachael De Leon conducted a (24 hour) 10-day complaint visit to the facility above. LPA De Leon met with the Administrator, Jodi Beltrama, and explained the purpose of the visit. The LPA requested the following records for R1 and R2: LIC 602 Physicians Reports, Appraisal Needs and Services Plan (ANS), Hospice Admit records, Hospice Agency Name and phone numbers, Hospice Care Plans, Medication Administration Records (MAR) for 10/2022-11/2022, Centrally Stored Medication and Destruction Records (CSMDR), Incident Reports, Death Reports, Death Certificates, Call pendant logs for 10/2022-11/2022, Staff and Hospice Notes 09/2022-11/2022, Resident Roster for 11/2022 and 01/2023 with telephone numbers, Staff and Hospice notes for 09/2022-11/2022, Staff 1 (S1) hire date at the facility and hire date of last promotion, Staff Roster with telephone numbers for 11/2022 and 01/2023. The LPA informed Administrator that the complaint was referred to the Community Care Licensing (CCL) Investigation Branch (IB).
On 03/23/2023 Investigator Munoz contacted the Reporting Party (RP); on 03/24/2023, from approximately 1:00pm to 1:15pm, contacted facility staff to schedule in-person interviews; on 03/27/2023, from approximately 9:30am to 10:10am, conducted interviews with staff; on 04/05/2023, at approximately 2:30pm, with RP; on 04/06/2023, from approximately 4:00pm to 4:05pm, left message for S1 and interviewed Administrator; on 04/11/2023, at approximately 1:40pm, left message for S1; and on 04/14/2023, at approximately 11:39am, interviewed S1. In addition, the investigator reviewed Wilshire Hospice Agency records related to R1 and R2, and facility file documents relevant to the investigation.
The Wilshire Hospice Agency records revealed that on 07/15/2022, R1 was admitted in hospice care and given a life expectancy of six months or less for hypertensive heart with Chronic Kidney Disease. On that same day, R1 was prescribed morphine, .25ml for mild pain, 0.5ml for moderate and 1ml for severe pain to be given every hour or as needed. On 09/26/2022, R1 showed signs of early transition. Over the span of R1’s care R1’s physical health declined as R1 decreased oral intake. R1’s ambulation capability declined and eventually was lost. R1 sustained multiple falls and a week prior to R1’s death R1 obtained a skin tear from an unknown origin per the facility. R1’s wound was painful, non-healing, and needed to be medicated around the clock. R1 became bedbound, non-verbal and began sleeping majority of the day. R1 spent one day actively dying until R1 passed quickly and comfortably in their room. R1 died on 11/02/2022. The death certificate listed the cause of death as Acute Cardiopulmonary Arrest, Congestive Heart Failure, Hypertensive Heart Disease.
Continued 9099-C pages |